BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Consumer Issues/Safety/Products CSP

Sunshine Act Implementation 21st Century Cures InitiativeGenetically Engineered (GE) Animals FDA Approval H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology H.R. 4432: Safe and Accurate Food Labeling Act Funding for FDA H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Drug Evaluation and Review Compassionate Use/Expanded Access Implementation of the FDA Safety and Innovation Act Special Medical Use/Limited Population Drug Biosimilars Colombia Biologics Regulations Implementation of Affordable Care Act Interchangeability and Pharmacy Substitution Naming USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products USDA Decision on GE Crops Environmental Impact Statement

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; Health Resources & Services Administration (HRSA); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO)

Bills named: H.R. 4800 (113th), H.R. 4432 (113th), S. 2389 (113th)

Food Industry (safety, labeling, etc.) FOO

Review and Labeling of Food Derived From Biotechnology H.R. 4432: Safe and Accurate Food Labeling ActGenetically Engineered (GE) Animals FDA Approval H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Amendment on GE Salmon Labeling

Contacted: Health Resources & Services Administration (HRSA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); SENATE; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Centers For Disease Control & Prevention (CDC)

Bills named: S. 2389 (113th), H.R. 4432 (113th), H.R. 4800 (113th)

Homeland Security HOM

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Contacted: Health Resources & Services Administration (HRSA); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA)

Trade (domestic/foreign) TRD

Intellectual Property International Enforcement Compulsory Licensing IndiaForeign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations Like-minded Countries Initiatives TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Transatlantic Trade and Investment Partnership Ag-Biotech Issues Intellectual Property Issues Regulatory Harmonization Reimbursement Transparency Biosimilars Colombia Biologics Regulations Clinical Trial Data Sharing and Disclosure EU Policies Canadian Policies

Contacted: SENATE; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Agriculture AGR

EPA Regulations on Agricultural Biotechnology Efficient Science-Based Review of Biotech ProductsGenetically Engineered (GE) Animals FDA Approval H.R. 4800/S. 2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology H.R. 4432: Safe and Accurate Food Labeling Act Funding for the USDA H.R. 4800/S. 2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Foreign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations Like-minded Countries Initiatives Funding for Biomass Crop Assistance Program H.R. 4800/S. 2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Transatlantic Trade and Investment Partnership Ag-Biotech Issues USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products USDA Decision on GE Crops Environmental Impact Statement

Contacted: Natl Security Council (NSC); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); SENATE; Health Resources & Services Administration (HRSA)

Bills named: H.R. 4800 (113th), S. 2389 (113th), H.R. 4432 (113th)

Taxation/Internal Revenue Code TAX

Bonus Depreciation S. 2260: EXPIRE Act of 2014Tax Reform Orphan Drug Act Tax Credit Renewable Chemicals/Bio-based Products Bonus Depreciation for Renewable Chemical Facilities S. 2260: EXPIRE Act of 2014 Biofuels Accelerated Depreciation Extension Production Tax Credit Extension H.R. 3758: Second Generation Biofuel Extension Act of 2013 S. 2260: EXPIRE Act of 2014 Research & Development Tax Credit Reforms Extension Permanency H.R. 4438: American Research & Competitiveness Act of 2014 S. 2260: EXPIRE Act of 2014 S. 2715: The COMPETE Act S.193: The Start-up Innovation Credit Act Capital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules H.R. 4855: The PARTNER Act S. 1658: The Start-up Jobs and Innovation Act S. 2715: The COMPETE Act Controlled Foreign Corporation Look-Through Rule Extension S. 2260: EXPIRE Act of 2014 Inversions H.R.4870: Department of Defense Appropriations Act for FY 2015 H.R.5016: Financial Services and General Government Appropriations Act for FY 2015

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 3758 (113th), H.R. 4870 (113th), S. 1658 (113th), S. 2260 (113th), S. 2715 (113th), S. 193 (113th), H.R. 4855 (113th), H.R. 4438 (113th), H.R. 5016 (113th)

Copyright/Patent/Trademark CPT

Patenting of Humanitarian Technologies S. 712: Patents for Humanity Program Improvement Act of 2013Patent Reform H.R. 3309: Innovation Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 1720: Patent Transparency and Improvements Act of 2013 S. 866: Patent Quality Improvement Act of 2013 Targeting Rogue and Opaque Letters (TROL) Act of 2014 (Discussion Draft) FTC Regulation of Patent Demand Letters (Senate Commerce Committee Discussion Draft) Intellectual Property International Enforcement Compulsory Licensing India Issues TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Patenting of Biological Inventions

Contacted: Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); Natl Security Council (NSC); Patent & Trademark Office (PTO); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA)

Bills named: S. 712 (113th), S. 866 (113th), H.R. 3309 (113th), S. 1720 (113th), S. 1013 (113th)

Health Issues HCR

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015Biosimilars Naming Colombia Biologics Regulations Implementation of Affordable Care Act Interchangeability and Pharmacy Substitution Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Vaccine Access/Financing Implementation of Affordable Care Act S.2694: Ensuring Access to Primary Care for Women and Children Act 340B Drug Pricing Program Implementation of Affordable Care Act Program Implementation & Oversight Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for FDA H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program CMS Proposed Rule on Protected Classes Sequestration of PDUFA Fees S. 1413: FDA User Fee Protection Act Drug Evaluation and Review Compassionate Use/Expanded Access Special Medical Use/Limited Population Drug Implementation of the FDA Safety and Innovation Act Orphan Drug Act Tax Credit Clinical Trial Data Sharing and Disclosure EU Policies Canadian Policies Sunshine Act Implementation Affordable Care Act Implementation Third Party Support of Patient Premiums and Cost-Sharing Obligations 21st Century Cures InitiativeTransPacific Partnership Regulatory Transparency Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Regulatory Harmonization Reimbursement Transparency Intellectual Property Issues

Contacted: Securities & Exchange Commission (SEC); SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC)

Bills named: H.R. 4800 (113th), S. 1413 (113th), S. 2389 (113th), S. 2694 (113th)

Small Business SMB

Sarbanes Oxley Section 404 (b) Mandatory Audit Firm Rotation H.R. 1564/S. 1526: The Audit Integrity and Job Protection ActCapital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules S. 1658: The Start-up Jobs and Innovation Act H.R. 4855: The PARTNER Act S.2715: The COMPETE Act Expansion of Exemption under SEC Regulation A H.R. 4565: Startup Capital Modernization Act Proposed SEC Rule on Reg A+ Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions H.R. 2629: The Fostering Innovation Act XBRL Exemption for Small Public Companies H.R. 4164: Small Company Disclosure Simplification Act H.R. 5405: The Promoting Job Creation and Reducing Small Business Burdens Act Stock Exchange Tick Size H.R. 3448: The Small Cap Liquidity Reform Act H.R. 1952: The Spread Pricing Liquidity Act Capital Market Enhancements H.R. 3623: Improving Access to Capital for Emerging Growth Companies Act H.R. 4568: Small Business Freedom to Grow Act H.R. 4569: Disclosure Modernization and Simplification Act H.R. 4571: To direct the SEC to revise its rules so as to increase the threshold amount for requiring issuers to provide certain disclosures relating to compensatory benefits plans H.R. 4697: To require the SEC to revise the definition of a WKSI to reduce the worldwide market value threshold under the definition

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health Resources & Services Administration (HRSA); Natl Security Council (NSC); SENATE

Bills named: S. 1526 (113th), H.R. 3623 (113th), H.R. 2629 (113th), H.R. 1564 (113th), H.R. 4571 (113th), H.R. 4697 (113th), H.R. 1952 (113th), H.R. 4569 (113th), H.R. 3448 (113th), H.R. 4164 (113th), H.R. 4855 (113th), S. 1658 (113th), H.R. 5405 (113th), H.R. 4568 (113th), S. 2715 (113th), H.R. 4565 (113th)

Medicare/Medicaid MMM

21st Century Cures Initiative Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program: CMS Proposed Rule on Protected Classes

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Natl Security Council (NSC); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Office of Management & Budget (OMB)

Budget/Appropriations BUD

Funding for the USDA H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for FDA H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for Biomass Crop Assistance Program H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Sequestration of PDUFA Fees S. 1413: FDA User Fee Protection Act Funding for Renewable Chemicals/Bio-based Products Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Biofuels H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015 H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biorefineries Implementation of the Agricultural Act of 2014 H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Contacted: Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); Natl Security Council (NSC); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC)

Bills named: S. 2389 (113th), H.R. 4923 (113th), S. 1413 (113th), H.R. 4800 (113th)

Energy/Nuclear ENG

Funding for Biofuels H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015 H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels (Non-Funding) Accelerated Depreciation Extension Climate Change Benefits Production Tax Credit Extension Renewable Fuel Standard H.R. 3758: Second Generation Biofuel Extension Act of 2013 S. 2260: EXPIRE Act of 2014 Renewable Chemicals/Bio-based Products (Non-Funding) Implementation of the Agriculture Act of 2014 Bonus Depreciation for Renewable Chemical Facilities S. 2260: EXPIRE Act of 2014 Funding for Biomass Crop Assistance Program H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Biorefineries Implementation of the Agricultural Act of 2014 H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Contacted: Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Natl Security Council (NSC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4800 (113th), H.R. 4923 (113th), S. 2389 (113th), S. 2260 (113th), H.R. 3758 (113th)

Animals ANI

Genetically Engineered (GE) Animals FDA Approval H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Amendment on GE Salmon Labeling

Contacted: Securities & Exchange Commission (SEC); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Food & Drug Administration (FDA)

Bills named: H.R. 4800 (113th), S. 2389 (113th)

Fuel/Gas/Oil FUE

Funding for Biofuels H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015 H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels (Non-Funding) Accelerated Depreciation Extension Climate Change Benefits Production Tax Credit Extension Renewable Fuel Standard H.R. 3758: Second Generation Biofuel Extension Act of 2013 S. 2260: EXPIRE Act of 2014 Renewable Chemicals/Bio-based Products (Non-Funding) Implementation of the Agriculture Act of 2014 Bonus Depreciation for Renewable Chemical Facilities S. 2260: EXPIRE Act of 2014 Funding for Biomass Crop Assistance Program H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Biorefineries Implementation of the Agricultural Act of 2014 H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Contacted: Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); SENATE; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Natl Security Council (NSC); Securities & Exchange Commission (SEC); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: S. 2260 (113th), S. 2389 (113th), H.R. 4923 (113th), H.R. 4800 (113th), H.R. 3758 (113th)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 21st Century Cures Initiative

Contacted: Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA)